2013Unpublished venueRequires access

Hypertension in autosomal dominant polycystic kidney disease

Frederic F. Rahbari-Oskoui, Arlene B. Chapman

Open publisher page 18 citations

Abstract

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease, characterized by gradual and progressive cyst growth and renal enlargement, resulting in a decline in kidney function and the development of renal failure. Hypertension is common and occurs early, prior to the loss of renal function, with 29 years being the mean age of diagnosis. The pathophysiology of hypertension is multifactorial and is characterized by hyperactivity of the renin–angiotensin–aldosterone system, activation of the sympathetic nervous system and endothelial dysfunction. Early antihypertensive therapy appears to postpone the development of renal failure and cardiovascular events in this disorder. This chapter reviews the epidemiology, pathophysiology and management of hypertension in autosomal dominant polycystic kidney disease.

About this research paper

What this paper is about

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease, characterized by gradual and progressive cyst growth and renal enlargement, resulting in a decline in kidney function and the development of renal failure. Hypertension is common and occurs early, prior to the loss of renal function, with 29 years being the mean age of diagnosis. The pathophysiology of hypertension is multifactorial and is characterized by hyperactivity of the renin–angiotensin–aldosterone system, activation of the sympathetic nervous system and endothelial dysfunction. Early antihypertensive therapy appears to postpone the development of renal failure and cardiovascular events in this disorder. This chapter reviews the epidemiology, pathophysiology and management of hypertension in autosomal dominant polycystic kidney disease.

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease, characterized by gradual and progressive cyst growth and renal enlargement, resulting in a decline in kidney function and the development of renal failure. Hypertension is common and occurs early, prior to the loss of renal function, with 29 years being the mean age of diagnosis. The pathophysiology of hypertension is multifactorial and is characterized by hyperactivity of the renin–angiotensin–aldosterone system, activation of the sympathetic nervous system and endothelial dysfunction. Early antihypertensive therapy appears to postpone the development of renal failure and cardiovascular events in this disorder. This chapter reviews the epidemiology, pathophysiology and management of hypertension in autosomal dominant polycystic kidney disease.

Key concepts: Autosomal dominant polycystic kidney disease, Medicine, Polycystic kidney disease, Disease, Internal medicine, Genetics, Biology, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Hypertension in autosomal dominant polycystic kidney disease — Research Paper | ScholarLens